Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Valdemar Hansens Vej 5, 2600, Glostrup, Copenhagen, Denmark.
Department of Neurorehabilitation / Traumatic Brain Injury, Rigshospitalet, Copenhagen, Denmark.
J Headache Pain. 2022 Jul 23;23(1):87. doi: 10.1186/s10194-022-01464-2.
The onset and duration of spontaneous migraine attacks are most often difficult to predict which, in turn, makes it challenging to study the neurobiologic underpinnings of the disease in a controlled experimental setting. To address this challenge, human provocation studies can be used to identify signaling molecules (e.g. calcitonin gene-related peptide, pituitary adenylate cyclase-activating polypeptide) that, upon intravenous or oral administration, induce migraine attacks in people with migraine and mild or no headache in healthy volunteers. This approach has proven to be valid for decades and plays an integral role in mapping signaling pathways underlying migraine pathogenesis and identification of novel drug targets. However, the question arises as to whether the pathogenic mechanisms of provoked and spontaneous migraine attacks differ. In this paper, we provide an opinionated discussion on the similarities and differences between provoked and spontaneous attacks based on the current understanding of migraine pathogenesis.
The PubMed database was searched in July 2022 for original research articles on human provocation studies that included participants with migraine. The reference lists of originally identified articles were also searched and we selected those we judged relevant.
People with migraine describe that provoked attacks resemble their spontaneous attacks and can be treated with their usual rescue medication. From a neurobiologic standpoint, provoked and spontaneous migraine attacks appear to be similar, except for the source of migraine-inducing substances (exogenous vs. endogenous source). In addition, provoked attacks can likely not be used to study the events that precede the release of migraine-inducing signaling molecules from sensory afferents and/or parasympathetic efferents during spontaneous attacks.
自发性偏头痛发作的发作和持续时间通常难以预测,这反过来又使得在受控实验环境中研究疾病的神经生物学基础变得具有挑战性。为了解决这一挑战,可以使用人体激发研究来识别信号分子(例如降钙素基因相关肽、垂体腺苷酸环化酶激活肽),这些分子在静脉内或口服给药后会在偏头痛患者中引发偏头痛发作,而在健康志愿者中则只会引起轻度或无头痛。这种方法已经被证明是有效的,并且在绘制偏头痛发病机制的信号通路和识别新的药物靶点方面发挥了重要作用。然而,人们不禁要问,诱发和自发性偏头痛发作的发病机制是否不同。在本文中,我们根据偏头痛发病机制的当前理解,对诱发和自发性发作之间的相似性和差异进行了有针对性的讨论。
2022 年 7 月,我们在 PubMed 数据库中搜索了包含偏头痛患者的人体激发研究的原始研究文章。我们还搜索了最初确定的文章的参考文献列表,并选择了我们认为相关的文章。
偏头痛患者描述说,诱发发作类似于他们的自发性发作,可以用他们通常的急救药物治疗。从神经生物学的角度来看,诱发和自发性偏头痛发作似乎相似,除了诱发物质的来源(外源性与内源性来源)不同。此外,诱发发作可能无法用于研究在自发性发作期间感觉传入和/或副交感传出纤维释放诱发偏头痛的信号分子之前发生的事件。